Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial.

MLA

Hansen, Christian Stevns, et al. “Metformin May Adversely Affect Orthostatic Blood Pressure Recovery in Patients with Type 2 Diabetes: Substudy from the Placebo-Controlled Copenhagen Insulin and Metformin Therapy (CIMT) Trial.” Cardiovascular Diabetology, vol. 19, no. 1, Sept. 2020, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12933-020-01131-3.

APA

Hansen, C. S., Lundby-Christiansen, L., Tarnow, L., Gluud, C., Hedetoft, C., Thorsteinsson, B., Hemmingsen, B., Wiinberg, N., Sneppen, S. B., Lund, S. S., Krarup, T., Madsbad, S., Almdal, T., Carstensen, B., Jørgensen, M. E., the CIMT study group, Almdal, T., Boesgaard, T. W., Breum, L., & Gade-Rasmussen, B. (2020). Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial. Cardiovascular Diabetology, 19(1), 1–10. https://doi.org/10.1186/s12933-020-01131-3

Chicago

Hansen, Christian Stevns, Louise Lundby-Christiansen, Lise Tarnow, Christian Gluud, Christoffer Hedetoft, Birger Thorsteinsson, Bianca Hemmingsen, et al. 2020. “Metformin May Adversely Affect Orthostatic Blood Pressure Recovery in Patients with Type 2 Diabetes: Substudy from the Placebo-Controlled Copenhagen Insulin and Metformin Therapy (CIMT) Trial.” Cardiovascular Diabetology 19 (1): 1–10. doi:10.1186/s12933-020-01131-3.